IPO Update: Patheon Public Once Again, Audentes To Move Into The Clinic

Two companies in the biopharma space began trading publicly this week, one to pay off debt, the other to fund an early-stage pipeline.

stock

While the biotech IPO season has been a bit light recently, two companies with very different aims snuck through the window this week, both pulling in a significant amount of capital, indicating investors are still willing to make a bet on the space – as long as it's the right bet.

Pharma services company Patheon NV debuted on the public market on July 21, bringing in a whopping $640m –...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip